Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
Semergen ; 50(4): 102156, 2024.
Article in English | MEDLINE | ID: mdl-38310834

ABSTRACT

Monacolin K is the major active component in red yeast rice (RYR) which is structurally identical to lovastatin and has the most powerful effect, in terms of reducing blood cholesterol levels. This review aimed to examine the effect and safety of different doses of monacolin K on blood cholesterol levels. PubMed and Cochrane were searched for articles published between 2012 and 2023 for clinical-trials and randomized-controlled-trials. Eligible studies included participants>18-years-old, of any gender and ethnicity. The intervention/exposure of interest was monacolin K. Hypercholesterolemia was considered the outcome of interest defined as the elevated total or low-density-lipoprotein (LDL) cholesterol levels. 12 randomized-controlled-trials were eligible for inclusion in the analysis including 769 participants>18-years-old. 11 out of 12 studies were assessed with high methodological quality and one study with low methodological quality. Monacolin K supplementation varied between 2mg and 10mg per day and the maximum period of supplementation was 12 weeks. All studies indicated a beneficial effect of monacolin supplementation on LDL and total cholesterol levels (p<0.05) regardless the dose and period of supplementation. Also, 3 of the included studies reported adverse side effects after treatment with monacolin K. Low doses of monacolin K equal to 3mg/day exert potential cholesterol-lowering effects although the number of relative studies is limited. Regarding the safety of monacolin K supplementation, findings seem to be more controversial and therefore, it is suggested for all patients treated with monacolin K to be routinely monitored regardless the dose of supplementation.


Subject(s)
Anticholesteremic Agents , Biological Products , Cholesterol, LDL , Dicarboxylic Acids , Dietary Supplements , Fatty Acids , Hypercholesterolemia , Lovastatin , Randomized Controlled Trials as Topic , Humans , Hypercholesterolemia/drug therapy , Lovastatin/administration & dosage , Lovastatin/adverse effects , Anticholesteremic Agents/administration & dosage , Anticholesteremic Agents/adverse effects , Cholesterol, LDL/blood , Dose-Response Relationship, Drug , Cholesterol/blood
2.
J Agric Food Chem ; 71(51): 20419-20440, 2023 Dec 27.
Article in English | MEDLINE | ID: mdl-38100516

ABSTRACT

Plants actively develop intricate regulatory mechanisms to counteract the harmful effects of environmental stresses. The ubiquitin-proteasome pathway, a crucial mechanism, employs E3 ligases (E3s) to facilitate the conjugation of ubiquitin to specific target substrates, effectively marking them for proteolytic degradation. E3s play critical roles in many biological processes, including phytohormonal signaling and adaptation to environmental stresses. Arabidopsis Toxicosa en Levadura (ATL) proteins, belonging to a subfamily of RING-H2 E3s, actively modulate diverse physiological processes and plant responses to environmental stresses. Despite studies on the functions of certain ATL family members in rice and Arabidopsis, most ATLs still need more comprehensive study. This review presents an overview of the ubiquitin-proteasome system (UPS), specifically focusing on the pivotal role of E3s and associated enzymes in plant development and environmental adaptation. Our study seeks to unveil the active modulation of plant responses to environmental stresses by E3s and ATLs, emphasizing the significance of ATLs within this intricate process. By emphasizing the importance of studying the roles of E3s and ATLs, our review contributes to developing more resilient plant varieties and promoting sustainable agricultural practices while establishing a research roadmap for the future.


Subject(s)
Arabidopsis Proteins , Arabidopsis , Arabidopsis/metabolism , Proteasome Endopeptidase Complex , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Ubiquitin/metabolism
3.
Clín. investig. arterioscler. (Ed. impr.) ; 35(5): 248-261, sep.-oct. 2023. ilus, tab
Article in Spanish | IBECS | ID: ibc-226513

ABSTRACT

Para el tratamiento de la hipercolesterolemia, además de aconsejar una alimentación saludable, puede ser conveniente recomendar alimentos funcionales o nutracéuticos con efecto hipolipemiante. Dado el progresivo incremento en el número de estos productos y su creciente utilización por la población, la Sociedad Española de Arteriosclerosis (SEA) ha creído conveniente revisar la información disponible, seleccionar los resultados de los estudios científicamente más sólidos y posicionarse sobre la utilidad de los mismos, para recomendar a los profesionales sanitarios y a la población general su potencial utilidad en términos de eficacia y sus posibles beneficios y limitaciones. Se han identificado los siguientes escenarios clínicos en los que se podrían utilizar estos productos y que se analizarán con más detalle en este documento: 1. Tratamiento hipolipemiante en sujetos con intolerancia a estatinas. 2. Tratamiento hipolipemiante «a la carta» en personas en prevención primaria. 3. Prevención cardiovascular a largo plazo en personas sin indicación de tratamiento hipolipemiante. 4. Pacientes con tratamiento hipolipemiante optimizado que no alcanzan objetivos terapéuticos. (AU)


In the management of hypercholesterolemia, besides advising a healthy, plant-based diet, it may be useful to recommend functional foods or nutraceutical with cholesterol-lowering properties. Given the progressive increase in the number of these products and their rising use by the population, the Spanish Society of Arteriosclerosis (SEA) has considered it appropriate to review the available information, select the results of the scientifically more robust studies and take a position on their usefulness, to recommend to health professionals and the general population their potential utility in terms of efficacy and their possible benefits and limitations. The following clinical scenarios have been identified in which these products could be used and will be analyzed in more detail in this document: (1) Hypolipidemic treatment in subjects with statin intolerance. (2) Hypolipidemic treatment «a la carte» in individuals in primary prevention. (3) Long-term cardiovascular prevention in individuals with no indication for lipid-lowering therapy. (4) Patients with optimized lipid-lowering treatment who do not achieve therapeutic objectives. (AU)


Subject(s)
Hypercholesterolemia/therapy , Dietary Supplements , Functional Food , Phytosterols/administration & dosage , Phytosterols/therapeutic use , Oryza , Cholesterol, LDL
4.
Clin Investig Arterioscler ; 35(5): 248-261, 2023.
Article in English, Spanish | MEDLINE | ID: mdl-36932013

ABSTRACT

In the management of hypercholesterolemia, besides advising a healthy, plant-based diet, it may be useful to recommend functional foods or nutraceutical with cholesterol-lowering properties. Given the progressive increase in the number of these products and their rising use by the population, the Spanish Society of Arteriosclerosis (SEA) has considered it appropriate to review the available information, select the results of the scientifically more robust studies and take a position on their usefulness, to recommend to health professionals and the general population their potential utility in terms of efficacy and their possible benefits and limitations. The following clinical scenarios have been identified in which these products could be used and will be analyzed in more detail in this document: (1) Hypolipidemic treatment in subjects with statin intolerance. (2) Hypolipidemic treatment «a la carte¼ in individuals in primary prevention. (3) Long-term cardiovascular prevention in individuals with no indication for lipid-lowering therapy. (4) Patients with optimized lipid-lowering treatment who do not achieve therapeutic objectives.


Subject(s)
Anticholesteremic Agents , Arteriosclerosis , Hypercholesterolemia , Humans , Anticholesteremic Agents/therapeutic use , Arteriosclerosis/prevention & control , Cholesterol , Dietary Supplements , Functional Food , Hypercholesterolemia/drug therapy
5.
J Exp Bot ; 73(1): 307-323, 2022 01 05.
Article in English | MEDLINE | ID: mdl-34436579

ABSTRACT

One of the major regulatory pathways that permits plants to convert an external stimulus into an internal cellular response within a short period of time is the ubiquitination pathway. In this study, OsATL38 was identified as a low temperature-induced gene that encodes a rice homolog of Arabidopsis Tóxicos en Levadura RING-type E3 ubiquitin (Ub) ligase, which was predominantly localized to the plasma membrane. OsATL38-overexpressing transgenic rice plants exhibited decreased tolerance to cold stress as compared with wild-type rice plants. In contrast, RNAi-mediated OsATL38 knockdown transgenic progeny exhibited markedly increased tolerance to cold stress relative to that of wild-type plants, which indicated a negative role of OsATL38 in response to cold stress. Yeast two-hybrid, in vitro pull-down, and co-immunoprecipitation assays revealed that OsATL38 physically interacted with OsGF14d, a rice 14-3-3 protein. An in vivo target ubiquitination assay indicated that OsGF14d was mono-ubiquitinated by OsATL38. osgf14d knockout mutant plants were more sensitive to cold stress than wild-type rice plants, indicating that OsGF14d is a positive factor in the response to cold stress. These results provide evidence that the RING E3 Ub ligase OsATL38 negatively regulates the cold stress response in rice via mono-ubiquitination of OsGF14d 14-3-3 protein.


Subject(s)
Oryza , 14-3-3 Proteins/genetics , Cold-Shock Response , Gene Expression Regulation, Plant , Oryza/genetics , Oryza/metabolism , Plant Proteins/genetics , Plant Proteins/metabolism , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Stress, Physiological , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism , Ubiquitination
6.
Rev Iberoam Micol ; 38(4): 159-167, 2021.
Article in English | MEDLINE | ID: mdl-34802898

ABSTRACT

BACKGROUND: Fungi of the genus Paracoccidioides are the etiological agents of paracoccidioidomycosis, a highly prevalent mycosis in Latin America. Infection in humans occurs by the inhalation of conidia, which later revert to the form of yeast. In this context, macrophages are positioned as an important line of defense, assisting in the recognition and presentation of antigens, as well as producing reactive oxygen species that inhibit fungal spreading. AIMS: The objective of this study was to identify differentially expressed proteins during the interaction between Paracoccidioides lutzii Pb01 strain and human U937 monocytes. METHODS: Two-dimensional electrophoresis, combined with mass spectrometry, was used to evaluate the differential proteomic profiles of the fungus P. lutzii (Pb01) interacting with U937 monocytes. RESULTS: It was possible to identify 25 proteins differentially expressed by Pb01 alone and after interacting with U937 monocytes. Most of these proteins are directly associated with fungal metabolism for energy generation, such as glyceraldehyde-3-phosphate dehydrogenase, and intracellular adaptation to monocytes. Antioxidant proteins involved in the response to oxidative stress, such as peroxiredoxin, cytochrome, and peroxidase, were expressed in greater quantity in the interaction with monocytes, suggesting their association with survival mechanisms inside phagocytic cells. We also identified 12 proteins differentially expressed in monocytes before and after the interaction with the fungus; proteins involved in the reorganization of the cytoskeleton, such as vimentin, and proteins involved in the response to oxidative stress, such as glioxalase 1, were identified. CONCLUSIONS: The results of this proteomic study of a P. lutzii isolate are novel, mimicking in vitro what occurs in human infections. In addition, the proteins identified may aid to understand fungal-monocyte interactions and the pathogenesis of paracoccidioidomycosis.


Subject(s)
Paracoccidioides , Paracoccidioidomycosis , Fungal Proteins/genetics , Humans , Monocytes , Proteomics
7.
Rev Iberoam Micol ; 38(4): 175-179, 2021.
Article in English | MEDLINE | ID: mdl-34511397

ABSTRACT

BACKGROUND: Data regarding yeast microbiota in goat milk is scarce. AIMS: To isolate and identify species of the genus Candida in milk samples from clinically healthy goats, and evaluate their enzymatic activity and biofilm formation. METHODS: 1092 milk samples from clinically healthy goats were collected and processed. The yeast isolates were identified by phenotypic, methods and their enzymatic activity (phospholipase, hemolysin and protease) and biofilm formation evaluated. RESULTS: We obtained 221 Candida isolates belonging to six species: Candida kefyr (35.7%), Candida guilliermondii (33%), Candida famata (23.5%), Candida glabrata (5.9%), Candida albicans (1.35%) and Candida parapsilosissensu lato (0.45%). Protease activity was detected in all Candida species while hemolysin activity was only present in C. kefyr, C. guilliermondii, C. famata and C. albicans. Only C. albicans showed phospholipase activity. With the exception of C. parapsilosis sensu lato, all Candida species formed biofilm, with 60.19% of the isolates being poor producers, 9.93% moderate producers, and 1.35% strong producers. CONCLUSIONS: The milk of clinically healthy goats contains several species of the genus Candida that could play a role as opportunistic pathogens in mastitis.


Subject(s)
Candida , Milk , Animals , Biofilms , Candida albicans , Female , Goats
8.
Rev. Ciênc. Méd. Biol. (Impr.) ; 20(2): 245-252, set 29, 2021. tab
Article in English | LILACS | ID: biblio-1354441

ABSTRACT

Introducción: Cryptococcus neoformans es una levadura encapsulada, que se encuentra en fuentes ambientales, incluyendo excrementos de palomas. Tiene una gran relevancia clínica porque es el agente etiológico de la criptococosis, considerada una causa importante de mortalidad en personas inmunocomprometidas en todo el mundo. Objetivo: determinar la prevalencia y susceptibilidad de C. neoformans aislados del suelo y excremento de palomas en la ciudad de Maceió ­ Alagoas, Brasil. Metodología: Se recolectaron 150 muestras (50 de excretas secas, 50 de excretas frescas y 50 del suelo) y cultivaron en Agar Dextrosa Sabouraud. Las colonias aisladas sugestivas de C. neoformans se sometieron a identificación y caracterización mediante análisis morfológicos, actividad de la enzima fenol-oxidasa, sensibilidad a la cicloheximida, desarrollo a 37°C, hidrólisis de urea, asimilación de carbono y nitrógeno y fenotipificación en medio canavanina-glicina-azul de bromotimol. La prueba de susceptibilidad antifúngica se realizó utilizando la técnica de difusión en agar. Resultados: se obtuvieron 36 (24%) muestras positivas para C. neoformans, de las cuales 33 fueron de excretas secas y 3 del suelo cercano al excremento. El perfil de susceptibilidad fue de 100.0% para anfotericina B y 87.4% para ketoconazol, no obstante, hubo un alto porcentaje de resistencia a fluconazol (91.5%) e itraconazol (80.0%). Conclusión: estos hallazgos confirman que las excretas de palomas secas son reservorios de C. neoformans en el medio ambiente, caracterizando un problema de salud única. Además, la anfotericina B exhibió una alta actividad in vitro, representando buena alternativa en el tratamiento de la criptococosis.


Introdução: Cryptococcus neoformans é um fungo leveduriforme encapsulado, encontrado em fontes ambientais, incluindo excretas de pombos. Apresenta grande relevância clínica por ser agente etiológico da criptococose, considerada importante causa de mortalidade em indivíduos imunocomprometidos em todo o mundo. Objetivo: determinar a prevalência e suscetibilidade de C. neoformans isolados do solo e de excretas de pombos na cidade de Maceió, Alagoas. Metodologia: foram coletadas 150 amostras (50 de excretas secas, 50 de excretas frescas e 50 do solo) e cultivadas em Ágar Sabouraud Dextrose. As colônias isoladas sugestivas de C. neoformans foram submetidas à identificação e caracterização por meio de análises morfológicas, atividade da enzima fenoloxidase, sensibilidade à cicloheximida, termotolerância à 37ºC, hidrólise da ureia, assimilação de carbono e nitrogênio e quimiotipagem em ágar L-canavanina-glicina-azul de bromotimol. O teste de suscetibilidade antifúngica foi realizado por meio da técnica de difusão em ágar. Resultados: foram obtidas 36 (24%) amostras positivas para C. neoformans, das quais 33 (91,6%) foram provenientes de excretas secas e 3 (8,3%) do solo próximo a excrementos. O perfil de suscetibilidade foi de 100,0% para a anfotericina B e 87,4% para o cetoconazol, não obstante, verificou-se alto percentual de resistência ao fluconazol (91,8%) e itraconazol (80%). Conclusão: estes achados confirmam que excretas de pombos secas são reservatórios de C. neoformans no ambiente, caracterizando um problema de saúde única. Além disso, a anfotericina B apresentou elevada atividade, in vitro, representando boa alternativa no tratamento da criptococose.


Subject(s)
Animals , Male , Female , Columbidae , Yeasts , Cryptococcosis , Cryptococcus neoformans
9.
Rev Argent Microbiol ; 53(3): 257-265, 2021.
Article in English | MEDLINE | ID: mdl-33454152

ABSTRACT

Many industries generate a considerable amount of wastewater containing toxic and recalcitrant dyes. The main objective of this research was to examine the biosorption capacity of Reactive Blue 19 and Reactive Red 141 by the Antarctic yeast Debaryomyces hansenii F39A biomass. Some variables, including pH, dye concentration, amount of adsorbent and contact time, were studied. The equilibrium sorption capacity of the biomass increased with increasing initial dye concentration up to 350mg/l. Experimental isotherms fit the Langmuir model and the maximum uptake capacity (qmax) for the selected dyes was in the range of 0.0676-0.169mmol/g biomass. At an initial dye concentration of 100mg/l, 2g/l biomass loading and 20±1°C, D. hansenii F39A adsorbed around 90% of Reactive Red 141 and 50% of Reactive Blue 19 at pH 6.0. When biomass loading was increased (6g/l), the uptake reached up to 90% for Reactive Blue 19. The dye uptake process followed a pseudo-second-order kinetics for each dye system. As seen throughout this research study, D. hansenii has the potential to efficiently and effectively remove dyes in a biosorption process and may be an alternative to other costly materials.


Subject(s)
Debaryomyces , Water Pollutants, Chemical , Adsorption , Biomass , Coloring Agents , Hydrogen-Ion Concentration , Textiles , Thermodynamics
10.
Rev Iberoam Micol ; 37(3-4): 104-106, 2020.
Article in English | MEDLINE | ID: mdl-33229297

ABSTRACT

BACKGROUND: Mortality rate of invasive Candida infections is raising mainly amongst immunocompromised patients. These infections are hard-to-treat mainly due to the increasing incidence of resistance. The overexpression of ATP-binding cassette and major facilitator superfamily transporters is the main responsible for the failure of antifungal therapies. In a Saccharomyces cerevisiae model, ß-lapachone inhibited Pdr5p, a transporter homologous to those found in Candida albicans. AIMS: To determine whether ß-lapachone reverses the resistance phenotype mediated by efflux transporters in C. albicans clinical isolates. METHODS: The antifungal activity of ß-lapachone combined with fluconazole was measured by agarose chemosensitization and microdilution assays. CaCdr2p and CaMdr1p activities were evaluated through fluorescent dyes accumulation. ATPase activity was assessed using transporter-enriched plasma membranes. RESULTS: ß-lapachone reverted antifungal resistance of S. cerevisiae and C. albicans strains overexpressing CaCdr2p and CaMdr1p transporters by inhibiting these proteins activities. CaCdr2p ATPase activity was not impaired by the compound. CONCLUSIONS: ß-lapachone is a promising drug candidate to be used as an adjuvant in the treatment of candidiasis caused by fluconazole-resistant C. albicans strains.


Subject(s)
Candida albicans , Fluconazole , Antifungal Agents/pharmacology , Drug Resistance, Fungal , Fluconazole/pharmacology , Humans , Microbial Sensitivity Tests , Naphthoquinones , Saccharomyces cerevisiae
11.
Rev. chil. obstet. ginecol. (En línea) ; 85(5): 442-449, 2020. tab
Article in Spanish | LILACS | ID: biblio-1508006

ABSTRACT

Introducción: Muchas veces se propagan mitos y creencias sobre la higiene íntima femenina, que podrían traer consecuencias en muchos aspectos. Objetivo: Determinar la asociación entre los mitos y creencias del cuidado e higiene íntima y los cuidados reales de higiene íntima en mujeres peruanas jóvenes. Método: Se realizó un estudio transversal analítico, que presentó una revisión del tema para realizar una encuesta de 21 interrogantes, en temas comunes en la higiene íntima, post piloto, se preguntó de su realización y la frecuencia semanal; esta última se asoció a variables socio-educativas. Resultados: De las 600 mujeres jóvenes encuestadas, hubo diferencia en cuanto la edad según la percepción del uso de ropa interior de algodón (p=0,013), la limpieza de la zona íntima de adelante hacia atrás (p<0,001), el uso de ropa interior no muy ajustada (p<0,001), el uso de ropa sintética (p=0,045), el uso de jabón exclusivo para la zona íntima (p<0,001), la edad de inicio de relaciones sexuales (p=0,031) y el uso de métodos anticonceptivos como causantes de flujo (p=0,008). En cuanto al ser o no estudiantes, hubo diferencia en la percepción de que el rasurado del pubis para la limpieza (p=0,018) y que los ejercicios de relajación disminuyen el flujo vaginal (p=0,030). Conclusiones: Se describió algunos mitos y creencias en cuanto a la limpieza íntima; a su vez, se encontró que algunas prácticas de higiene tienen asociación con la edad y el ser estudiante. Esto debe ser estudiado a profundidad, ya que, esto podría llevar a problemas mayores.


Introduction: Myths and beliefs about female intimate hygiene are often spread, which could have consequences in many aspects. Objective: To determine the association between the myths and beliefs of intimate care and hygiene and the actual care of intimate hygiene in young Peruvian women. Method: An analytical cross-sectional study was conducted, which exposed a review of the topic to conduct a survey of 21 questions on common issues in intimate hygiene, post pilot, asked about its performance and weekly frequency; The latter was associated with socio-educational variables. Results: Of the 600 young women surveyed, there was a difference regarding age according to the perception of the use of cotton underwear (p = 0.013), the cleaning of the intimate area from front to back (p <0.001), the use of underwear not very tight (p <0.001), the use of synthetic clothing (p = 0.045), the use of exclusive soap for the intimate area (p <0.001), the age of onset of sexual intercourse (p = 0.031) and the use of contraceptive methods as causing flow (p = 0.008). Regarding whether or not they were students, there was a difference in the perception that shaving the pubis for cleaning (p = 0.018) and that relaxation exercises decrease vaginal discharge (p = 0.030). Conclusions: Some myths and beliefs regarding intimate cleansing were described; In turn, some hygiene practices were found to be associated with age and being a student. This should be studied in depth, as this could lead to bigger problems.


Subject(s)
Humans , Female , Adolescent , Young Adult , Candidiasis, Vulvovaginal/prevention & control , Health Knowledge, Attitudes, Practice , Hygiene , Peru , Self Care , Cross-Sectional Studies , Surveys and Questionnaires , Gynecological Examination
12.
Colomb. med ; 50(4): 293-298, Oct.-Dec. 2019.
Article in English | LILACS | ID: biblio-1114722

ABSTRACT

Abstract Background: Candida auris is an emerging yeast frequently reported as resistant to multiple antifungal drugs commonly used to treat Candida infections. This specie can colonize the patient's skin and has great ability for producing outbreaks in hospitals. C. auris is phylogenetically related to other Candida species, can be misidentified using conventional biochemical or commercial methods and requires specific technology for its identification. Case report: We report the first isolate of C. auris in Cali, Colombia, from a central venous catheter in a 37-year-old patient with rheumatoid arthritis and endocarditis who did not have symptoms of sepsis. The yeast was initially misidentified as C. haemulonii using the Phoenix system and subsequently identified as C. auris by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS). The broth microdilution method was used to determine the minimum inhibitory concentration; the isolate was susceptible to fluconazole, itraconazole, voriconazole and amphotericin B. Conclusions: This report contributes to knowledge of the epidemiology of C. auris infections in individuals with underlying disease and describes an isolate with a behavior different from what is usually reported.


Resumen Antecedentes: Candida auris es una levadura emergente, informada con frecuencia como resistente a diversos antifúngicos usados comúnmente para tratar infecciones por Candida. Esta especie puede colonizar la piel y tiene gran capacidad de producir brotes en ambientes hospitalarios. Está filogenéticamente relacionada con otras especies de Candida, es mal identificada por los métodos bioquímicos o comerciales, y requiere tecnología específica para su identificación. Reporte de caso: Se informa el primer aislamiento de C. auris en Cali, Colombia en un paciente de 37 años con artritis reumatoide y endocarditis, sin síntomas de sepsis, a partir de la punta de catéter venoso central. La levadura inicialmente se identificó como C. haemulonii por el sistema Phoenix® y posteriormente como C. auris por espectrometría de masas desorción/ionización láser asistida por una matriz con detección de masas por tiempo de vuelo (MALDI-TOF MS). Se determinó la concentración inhibitoria mínima por el método de microdilución en caldo que mostró un aislamiento sensible a fluconazol, itraconazol, voriconazol y anfotericina B. Conclusión: Este informe contribuye al conocimiento de la epidemiología de las infecciones por C. auris en individuos con enfermedad subyacente y describe un aislamiento con un comportamiento diferente a lo indicado en otros estudios.


Subject(s)
Adult , Humans , Male , Candida/isolation & purification , Candidiasis/diagnosis , Catheter-Related Infections/diagnosis , Antifungal Agents/administration & dosage , Candidiasis/microbiology , Candidiasis/drug therapy , Catheterization, Central Venous/adverse effects , Microbial Sensitivity Tests , Colombia , Catheter-Related Infections/microbiology , Catheter-Related Infections/drug therapy
13.
Rev Iberoam Micol ; 36(3): 129-138, 2019.
Article in English | MEDLINE | ID: mdl-31690527

ABSTRACT

BACKGROUND: The prevalence of opportunistic yeast infections has increased in recent decades as the result of an increasing immunocompromised patient population. AIMS: To evaluate ribosomal RNA (rRNA) gene sequence to identify medically important yeast species, to investigate the performance of both the rRNA gene internal transcribed spacer (ITS) and D1/D2 region in identifying clinically relevant yeasts, and to compare these results with those of a standard phenotypic method. METHODS: Both regions from 50 yeast strains, comprising 45 clinical isolates and 5 reference strains, were amplified using PCR and then sequenced. The sequences were compared to reference data available from the GenBank database of the National Center for Biotechnology Information using the BLASTn tool. RESULTS: Using ID32C, 88% (44/50) of all strains were identified accurately at the species level, although 6% were misidentified; two Candida eremophila isolates were identified as Candida glabrata and Candida tropicalis, and one Saprochaete clavata isolate was identified as Saprochaete capitata. Two of the four isolates identified by phenotypic methods as Trichosporon asahii were defined so by analyzing the ITS region, but the remaining two were not distinguishable from closely related species. Based on the D1/D2 region, these four isolates had 100% sequence identity with T. asahii, Trichosporon japonicum, and Trichosporon asteroides. The isolate identified as Trichosporon inkin using ID32C could not be distinguished from Trichosporon ovoides by analyzing the ITS and D1/D2 regions. CONCLUSIONS: Identifying medically important yeasts by sequencing the ITS and D1/D2 region is a rapid and reliable alternative to conventional identification methods. For a diagnostic algorithm, we suggest a two-step procedure integrating conventional methods (e.g. microscopic morphology on corn meal agar with Tween® 80 and API ID32C®) and sequence analysis of the ITS and D1/D2 region.


Subject(s)
DNA, Fungal/analysis , Ribosome Subunits, Large/genetics , Yeasts/genetics , Base Sequence , Humans , Yeasts/isolation & purification
14.
West Indian med. j ; 68(2): 129-135, 2019. tab, graf
Article in English | LILACS | ID: biblio-1341857

ABSTRACT

ABSTRACT Objective: Despite the presence of multitude of synthetic drugs against fever and inflammation, none has been proven entirely safe. In contrast, the accepted safety of plant derived natural products is inspiring the world. Based on this fact as well as in view of the diversified activities reported from the genus Gymnosporia, the present study was designed to evaluate the antipyretic and anti-inflammatory activity of Gymnosporia royleana (G royleana). Methods: The methanolic extract of the aerial parts of G royleana was screened for in-vivo antipyretic activity using the brewer's yeast-induced pyrexia mice model and for anti-inflammatory activity using the carrageenan-induced paw oedema and xylene-induced ear oedema mice model. Results: In the antipyretic assay, G royleana extract showed considerable antipyretic activity in a dose dependent fashion. Statistically significant antipyretic effects (p < 0.05) were observed at the end of the second hour of administration for all doses of extract and remained significant until the end of the experiment. The plant extract also displayed promising anti-inflammatory activity, in a dose dependent fashion, in both models of inflammation ie carrageenan- and xylene-induced oedema models, when compared to the controls. In the carrageenan-induced oedema model, significant effects (p < 0.01) were observed for 300 and 600 mg/kg doses after 60 minutes of xylene administration (ie 55.51% and 65.88% inhibition of oedema, respectively). Conclusion: The study provided evidence supporting the antipyretic and anti-inflammatory activity of the G royleana methanolic extract.


RESUMEN Objetivo: A pesar de la presencia de multitud de fármacos sintéticos en el arsenal contra la fiebre y la inflamación, ninguno ha dado pruebas de ser completamente seguro. En contraste con ello, la seguridad aceptada de los productos naturales derivados de las plantas inspira al mundo. Sobre la base de este hecho, así como en vista de las actividades diversificadas que se reportan con respecto al género Gymnosporia, el presente estudio se diseñó con el objeto de evaluar el potencial antipirético y antiinflamatorio de Gymnosporia royleana (G royleana). Métodos: El extracto de metanol de las partes aéreas de G royleana fue tamizado en busca de actividad antipirética in vivo, utilizando el modelo de pirexia inducida por levadura de cerveza en ratones, y de actividad antiinflamatoria utilizando modelos de ratones con oedema de las patas inducido mediante carragenina, y oedema de las orejas inducido mediante xileno. Resultados: En el ensayo antipirético, el extracto de G royleana mostró una actividad antipirética considerable en forma dependiente de la dosis. Se observó un efecto antipirético estadísticamente significativo (p < 0.05) en el transcurso de la segunda hora de administración para todas las dosis de extracto y se mantuvo significativo hasta el final del experimento. El extracto de la planta también mostró una actividad antiinflamatoria prometedora, de una manera dependiente de la dosis, en ambos modelos de inflamación, es decir, modelos de oedema inducido por carragenina y xileno, en comparación con el control. En el modelo de oedema inducido por carragenina, se observó un efecto significativo (p < 0.01) para dosis de 300 y 600 mg / kg después de 60 minutos de administración de xileno (es decir, 55.51% y 65.88% de inhibición del oedema, respectivamente). Conclusión: El estudio proporcionó pruebas suficientes sobre el potencial antipirético y antiinflamatorio del extracto de G royleana.


Subject(s)
Animals , Mice , Plant Extracts/pharmacology , Celastraceae/chemistry , Antipyretics/pharmacology , Fever/drug therapy , Phytotherapy , Anti-Inflammatory Agents/pharmacology , Saccharomyces cerevisiae , Disease Models, Animal , Fever/chemically induced
15.
Rev Iberoam Micol ; 35(2): 63-67, 2018.
Article in English | MEDLINE | ID: mdl-29605496

ABSTRACT

BACKGROUND: Posaconazole is used for the prophylaxis of invasive fungal disease (IFD). Previous studies have shown it to be cost-effective compared to fluconazole/itraconazole. However, posaconazole has never been economically evaluated in developing countries. AIMS: The aim of the present study was to perform a cost-effectiveness analysis of posaconazole compared to fluconazole in public (SUS) and private hospitals (PHS) in Brazil. METHODS: A cost-effectiveness simulation was conducted on the basis of a pivotal study on the use of posaconazole in acute myeloid leukemia (AML) patients, adjusting the costs to Brazilian data. RESULTS: A pharmacoeconomic analysis was performed on a hypothetical sample of 100 patients in each drug group. The total cost of posaconazole use alone was USD$ 220,656.31, whereas that for fluconazole was USD$ 83,875.00. Our results showed that patients with IFD remain hospitalized for an additional 12 days, at an average cost of USD$ 850.85 per patient per day. The total money spent by PHS for 100 patients for 100 days was USD$ 342,318.00 for the posaconazole group and USD$ 302,039.00 for the fluconazole group. An analysis of sensitivity (10%) revealed no intergroup difference. CONCLUSIONS: In Brazil posaconazole is cost-effective, and should be considered for the prophylaxis of patients with AMD/myelodysplasia (AML/MDS) undergoing chemotherapy.


Subject(s)
Antifungal Agents/economics , Drug Costs/statistics & numerical data , Hospitals, Private/economics , Hospitals, Public/economics , Mycoses/prevention & control , Triazoles/economics , Brazil , Chemotherapy-Induced Febrile Neutropenia/complications , Cost of Illness , Cost-Benefit Analysis , Developing Countries/economics , Fluconazole/economics , Humans , Immunocompromised Host , Itraconazole/economics , Leukemia, Myeloid, Acute/complications , Mycoses/economics , Mycoses/etiology
16.
Clin. biomed. res ; 38(2): 111-115, 2018.
Article in Spanish | LILACS | ID: biblio-1024805

ABSTRACT

Introducción: Cryptococcus neoformans es un hongo levaduriforme encapsulado, de distribución mundial, principalmente en regiones tropicales, causando infecciones en individuos inmunocomprometidos, sobre todo en los infectados con el virus de la inmunodeficiencia humana (HIV). La capacidad de infección de este hongo es variable, pudiendo citar la facultativa patogenicidad, cápsula con actividad fagocitaria y producción de melanina como antioxidante. El objetivo de este trabajo fue evaluar el uso de la PCR/ RFLP para la detección e identificación de C. neoformans directamente del líquido cefalorraquídeo (LCR) de pacientes ingresados en un hospital público de la ciudad de Lages, Estado de Santa Catarina, sur de Brasil, comparando el resultado con la tinción específica para el hongo y el crecimiento en medio de cultivo. Métodos: Las muestras fueran directamente teñidas con tinta china para observar la cápsula, bien como después sembladas en medio de cultivo (agar dextrosa Sabouraud y agar de Níger) para crecimiento fúngico; también se hizo la extracción del ADN con fenol-cloroformo. La técnica fue utilizada para amplificación del gen URA5 mediante reacción en cadena de la polimerasa (PCR) y después con las enzimas de restricción HhaI y Sau96I para genotipaje mediante la PCR-RFLP. Resultados: En dos muestras fueran aislados C. neoformans con la tinción china y amplificados en la PCR, en las cuales fueran identificados como var. grubii. Conclusión: El serotipo A var. grubii es lo más aislado en la criptococosis humana, principalmente en pacientes HIV, pero se desconoce la preferencia de este serotipo por este grupo de enfermos. (AU)


Introduction: Cryptococcus neoformans is an encapsulated yeast with worldwide circulation, predominantly in tropical regions, causing infections in immunocompromised individuals, particularly those infected with human immunodeficiency virus (HIV). The virulence of this fungus is variable, and it should be mentioned the facultative pathogenicity, capsule with anti-phagocytic activity, and antioxidant melanin production. The aim of this study was to evaluate the use of polymerase chain reaction (PCR)/ restriction fragment length polymorphism (RFLP) for detection and identification of C. neoformans directly from the cerebrospinal fluid (CSF) of patients admitted to a public hospital with suspected meningitis and/or meningoencephalitis in the city of Lages, Santa Catarina, southern Brazil. Results were compared using Chinese ink and growth media. Methods: The samples were submitted to direct examination with Chinese ink for capsule observation, then to growth on culture media (Sabouraud Agar and Niger), with subsequent DNA extraction with phenol-chloroform. PCR was the technique used for amplification of URA5 gene, and then restriction enzymes HhaI and Sau96I were used for genotyping by PCR-RFLP. Results: In two samples, C. neoformans were isolated by Chinese ink and amplified by PCR. They were identified as serotype var. grubii. Conclusion: C. neoformans var. grubii is the most commonly isolated in human cryptococcosis, mainly in HIV patients. However, the preference of this serotype for this group of patients is unknown. (AU)


Subject(s)
Humans , Animals , Male , Female , Adult , Cryptococcosis/cerebrospinal fluid , Cryptococcus neoformans/pathogenicity , Cryptococcosis/diagnosis , Cryptococcosis/microbiology
17.
Rev. colomb. cienc. pecu ; 30(4): 299-307, oct.-dic. 2017. tab
Article in Spanish | LILACS | ID: biblio-900628

ABSTRACT

Resumen Antecedentes: Las micotoxinas representan pérdidas económicas significativas para la industria porcina, por lo que los adsorbentes de pared celular de levadura son una alternativa para reducir este problema. Objetivo: Evaluar la eficacia de un aditivo anti-micotoxinas (AAM; Safmannan®) en la prevención de micotoxicosis resultante de la ingesta de zearalenona (ZEA). Métodos: Fueron utilizadas 36 hembras porcinas jóvenes, cuyas dietas incorporaron dos niveles de inclusión del AAM (basado en la pared celular de Saccharomyces cerevisiae; 0 y 0,2%) y tres niveles de inclusión de ZEA (0, 0,25 y 0,6 ppm). El ensayo tuvo una duración total de 21 d, durante los cuales se efectuaron evaluaciones semanales de peso corporal, ganancia de peso, consumo de alimento y el volumen de la vulva. Igualmente, se midieron los pesos relativos de hígado, tracto reproductivo total y el conjunto útero-ovario-vagina. Resultados: Los resultados obtenidos comprueban la eficacia del AMA utilizado, toda vez que su suplementación evitó los efectos tóxicos de ZEA y mejoró los índices en órganos reproductivos como el volumen de la vulva, peso relativo del tracto reproductivo y el conjunto útero-ovario-vagina en animales intoxicados. Sin embargo, los efectos anti-micotoxinas fueron fijos para ambos niveles (0,25 y 0,6 ppm) de ZEA. Conclusión: La adición de AAM en las dietas que contienen ZEA demostró ser una alternativa eficiente para reducir los efectos tóxicos de esta micotoxina.


Abstract Background: Mycotoxins are a significant cause of economic losses in swine farming and adsorbents based on yeast cell walls provide an alternative solution to reducing this challenge. Objective: To evaluate the efficacy of an antimycotoxin additive (AMA; Safmannan®) for preventing the toxic effects of zearalenone (ZEA). Methods: A total of 36 pre-pubertal gilts were used, whose diets consisted of two different levels of AMA (based on the yeast cell wall of Saccharomyces cerevisiae; 0 and 0.2%) and three inclusion levels of ZEA (0, 0.25, and 0.6 ppm). The experiment was conducted for a period of 21 d and the following parameters were measured weekly: Live weight, weight gain, feed intake, and vulvar volume. The relative weight of the liver and the entire reproductive tract, including the uterus-ovary-vagina combined were also measured. Results: There was a significant enhancement in the index characteristics of reproductive organs like vulvar volume, weight of the entire reproductive tract and weight of the uterus-ovary-vagina of the intoxicated animals. The antimycotoxin effects were the same, irrespective of the ZEA levels (0.25 and 0.6 ppm). Conclusion: The addition of AMA to diets containing ZEA proved to be an effective alternative for reducing the toxic effects of this mycotoxin.


Resumo Antecedentes: As micotoxinas determinam perdas econômicas importantes para suinocultura e os adsorventes à base de parede celular de leveduras são uma alternativa para reduzir este problema. Objetivo: Avaliar a eficácia de um aditivo anti-micotoxina (AAM; Safmannan®) na prevenção da micotoxicose decorrente da ingestão de zearalenona (ZEA). Métodos: Foram utilizadas 36 leitoas pré-púberes, cujas dietas apresentaram dois níveis de inclusão de AAM (à base de parede celular de Saccharomyces cerevisiae; 0 e 0,2%) e três níveis de inclusão de ZEA (0, 0,25 e 0,6 ppm). O período experimental teve duração total de 21 d, sendo realizadas avaliações semanais de peso vivo, ganho de peso, consumo de ração e volume vulvar. Pesos relativos de fígado, trato reprodutivo total e o conjunto útero-ovário-vagina também foram calculados. Resultados: Os resultados obtidos demonstram a eficácia do AAM, pois a sua inclusão demonstrou prevenir os efeitos tóxicos da ZEA, já que os índices em órgãos reprodutivos como volume vulvar, peso relativo do trato reprodutivo total e do conjunto útero-ovário-vagina foram maiores nos animais intoxicados e sem suplementação. Porém, o efeito anti-micotoxina foi fixo, sendo o mesmo para os dois níveis de ZEA (0.25 e 0.6 ppm). Conclusão: A adição do AAM em questão nas dietas contendo ZEA demonstrou ser uma alternativa eficiente para redução dos efeitos tóxicos desta micotoxina.

18.
Rev. colomb. cienc. pecu ; 29(3): 169-177, jul.-set. 2016. tab
Article in English | LILACS | ID: biblio-959970

ABSTRACT

Summary Background: contamination of barley with Fusarium mycotoxins causes significant economic losses for pork producers, and alleviation with mycotoxin sequestering agents has proven inconsistent. Objective: to evaluate a yeast cell wall product in preventing adverse effects of Fusarium mycotoxins on growth performance, blood characteristic, and nutrient digestibility in gilts fed diets containing barley naturally contaminated with Fusarium mycotoxins. Methods: positive and negative controls of corn-soybean meal diets containing 20% control and contaminated barley with Fusarium mycotoxins, respectively, were prepared. Two additional diets were prepared by adding 0.2 or 0.4% of a yeast cell wall product to the negative control diet. The experimental diets were fed to pigs with 61.7 Kg initial body weight for 2 weeks. Results: pigs fed the negative control diet gained less than those fed the positive control diet (p<0.05) from d 0 to 7 and during the overall period, but nutrient digestibility and blood characteristics were not affected by feeding the contaminated diet. Most measurements were not affected by supplementing the yeast cell wall to the negative control diet. Conclusion: addition of the yeast cell wall product to negative control diets failed to ameliorate the adverse effects of dietary Fusarium mycotoxin on growth performance.


Resumen Antecedentes: la contaminación de la cebada con micotoxinas de Fusarium causa importantes pérdidas económicas para los productores de carne de cerdo, pero adsorbentes de micotoxinas para prevenir los efectos perjudiciales de las micotoxinas no dieron resultados consistentes. Objetivo: evaluar el producto de la pared celular de la levadura en la prevención de los efectos adversos de las micotoxinas de Fusarium sobre el crecimiento, características de la sangre, y la digestibilidad de nutrientes en cerdas jóvenes alimentadas con dietas que contienen cebada naturalmente contaminada con micotoxinas de Fusarium. Métodos: se prepararon las dietas a base de harina de maíz-soja de control positivo y negativo contienen 20% de control y cebada contaminados con micotoxinas de Fusarium, respectivamente. Adicionalmente se prepararon 2 dietas con productos de la pared celular de levadura de 0,2 o 0,4% a la dieta de control negativo. Fueron alimentados con las dietas experimentales cerdos con un peso corporal inicial de 61,7 Kg durante 2 semanas. Resultados: los cerdos alimentados con la dieta control negativo ganaron menos que aquellos alimentados con la dieta control positivo (p<0,05) a partir del d 0 a 7 y durante el período en general, pero la digestibilidad de los nutrientes y características de la sangre no fueron afectados por la alimentación de la dieta contaminada. La mayoría de las mediciones no fueron afectadas por la suplementación de la pared celular de la levadura con la dieta control negativo. Conclusión: la adición del producto de pared celular de levadura a la dieta control negativo no logró aminorar los efectos adversos de las micotoxinas de Fusarium sobre el crecimiento.


Resumo Antecedentes: a contaminação da cevada com a micotoxinas Fusarium causa perdas econômicas significativas para os produtores de suínos, porèm os adsorventes de micotoxinas que evitam efeitos prejudiciais de micotoxinas não deram resultados consistentes. Objetivo: avaliar o produto da parede celular das leveduras para prevenir efeitos adversos da micotoxinas Fusarium no desempenho do crescimento, inchaço da vulva, característica do sangue, digestibilidade dos nutrientes em porcas jòvens que são alimentadas com dietas contendo a cevada naturalmente contaminada com micotoxinas do Fusarium. Métodos: foram preparadas dietas de controle positivo e negativo à base de milho e soja, contendo 20% do controle e cevada contaminada com micotoxinas Fusarium, respectivamente. Duas dietas adicionais foram preparadas complementando com 0,2 ou 0,4% o produto da parede celular das leveduras à dieta do controle negativo. As dietas experimentais foram fornecidas aos suínos com peso corporal inicial de 61,7 Kg por 2 semanas. Resultados: os suínos alimentados com a dieta do controle negativo ganharam menos peso do que aqueles alimentados com a dieta do controle positivo (p<0,05) a partir do dia 0 até 7 durante todo o período, a digestibilidade dos nutrientes e as características do sangue não foram afetadas pela alimentação da dieta contaminada. A maioria das medidas não foram afetadas pela complementação da parede celular das leveduras à dieta do controle negativo. Conclusão: a complementação do produto da parede celular das leveduras nas dietas de controle negativo não conseguiu melhorar o efeito adverso das micotoxinas Fusariume no desempenho de crescimento.

19.
Rev. colomb. biotecnol ; 18(1): 148-164, ene.-jun. 2016. ilus, tab
Article in Spanish | LILACS | ID: lil-791242

ABSTRACT

En el presente trabajo, se efectuó una compilación de investigaciones realizadas sobre las diferentes etapas del proceso productivo del mezcal a partir de agave en algunas regiones productoras de México; con el propósito de explicar las problemáticas que enfrenta la cadena productiva agave-mezcal y las estrategias científicas que se han desarrollado para solucionarlas. Con ello se pretende lograr su resistencia y persistencia productiva en el mercado, elaborando un producto que cumpla con las características químicas establecidas por las normas oficiales mexicanas de producción y certificación de calidad, además de ofrecer posibles medidas de control en los procesos para estandarizar el producto y finalmente lograr etapas más eficientes en el proceso de producción.


In this paper, a compilation of investigations of the different stages in the production process of mezcal from agave in some producers regions of Mexico is carried out; to explain some of the problems faced by the productive chain agave-mezcal and scientific strategies that are being developed in the country to solve them. This is intended to achieve its resistance and productive persistence in the market, producing a product that meets the chemical characteristics established by the Mexican official standards of production and quality certification, in addition to establishing more measures of control processes to standardize the product and finally to achieve more efficient steps in the production process.

20.
Biochem Biophys Res Commun ; 469(1): 8-14, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26612255

ABSTRACT

Plants have developed a variety of complicated responses to cope with drought, one of the most challenging environmental stresses. As a quick response, plants rapidly inhibit stomatal opening under the control of abscisic acid (ABA) signaling pathway, in order to preserve water. Here, we report that Arabidopsis Tóxicos en Levadura (ATL), a RING-type E3 ubiquitin ligase, mediates the ABA-dependent stomatal closure. In contrast to wild-type plants, the stomatal closure was fully impaired in atatl78 mutant plants even in the presence of exogenous ABA and reactive oxygen species (ROS). Besides, under high concentrations of Ca(2+), a down-stream signaling molecule of ABA signaling pathway, atatl78 mutant plants successfully closed the pores. Furthermore, AtATL78 protein indirectly associated with catalases and the deficiency of AtATL78 led the reduction of catalase activity and H2O2, implying the function of AtATL78 in the modulation of ROS activity. Based on these results, we suggest that AtATL78 possibly plays a role in promoting ROS-mediated ABA signaling pathway during drought stress.


Subject(s)
Abscisic Acid/metabolism , Arabidopsis/physiology , Droughts , Signal Transduction/physiology , Stress, Physiological/physiology , Ubiquitin-Protein Ligases/metabolism , Adaptation, Physiological/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...